Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/8929
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuniandy, Giritharan-
dc.contributor.authorKamaruzaman, Lydia-
dc.contributor.authorHui Jan, Tan-
dc.contributor.authorMohd, Rozita-
dc.contributor.authorNeesam Mariamutu, Theepa-
dc.contributor.authorVoon Ken, Fong-
dc.contributor.authorKiew Beng, Pau-
dc.contributor.authorMustafar, Ruslinda-
dc.date.accessioned2024-12-13T07:50:26Z-
dc.date.available2024-12-13T07:50:26Z-
dc.date.issued2023-01-01-
dc.identifier.issn2338-2732-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/8929-
dc.description.abstractAbstt Cefepime is a frequently used fourth-generation cephalosporin antibiotic for a wide variety of infections. Toxic levels of this drug can cause neurological complications. The most common neurological adverse event of cefepime is headache and lightheadedness. Here, we presented a case of cefepime induced encephalopathy in a 57-year-old female patient with acute on chronic kidney disease. With an accurate diagnosis that requires a high index of clinical suspicion, prompt management was instituted. She had full resolution of symptoms following discontinuation of the medication and also emergent dialysis. Keywords: Cefepime, encephalopathy, chronic kidney disease.en_US
dc.language.isoenen_US
dc.publisherPerhimpunan Dokter Spesialis Penyakit dalam Indonesiaen_US
dc.subjectCefepime,en_US
dc.subjectencephalopathy,en_US
dc.subjectchronic kidney disease.en_US
dc.titleCefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Reporten_US
dc.typeArticleen_US
Appears in Collections:VOL 55 NO 1 2023

Files in This Item:
File Description SizeFormat 
78-82.pdf814.98 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.